BGI Genomics Co., Ltd. (300676.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
About BGI Genomics Co., Ltd.
—
BGI Genomics Co., Ltd. (300676.SZ) stock trades at $39.97 with a market capitalization of $15.43B. The stock is valued at a negative price-to-earnings (P/E) ratio of -26.72, reflecting a net loss over the last twelve months, price-to-book of 1.82, price-to-sales of 3.99. Over the past 52 weeks the stock has ranged between $32.55 and $65.00, and currently trades 38.5% below its 52-week high.
On profitability, BGI Genomics Co., Ltd. generates a return on equity (ROE) of -6.60% (negative, reflecting a net loss), an operating margin of 3.45%, a net profit margin of -14.89%.
The balance sheet shows a debt-to-equity ratio of 0.06 (debt below half of shareholders' equity), a current ratio of 2.81.
300676.SZ has an average daily trading volume of 9,534,684 shares, a beta of 0.69 (historically less volatile than the overall market), 0.42B shares outstanding.
Official website: www.bgi.com
BGI Genomics Co., Ltd. (300676.SZ) — frequently asked questions
What is BGI Genomics Co., Ltd. (300676.SZ) stock price today?
BGI Genomics Co., Ltd. (300676.SZ) is currently trading at $39.97, down 4.79% today.
What is 300676.SZ P/E ratio?
BGI Genomics Co., Ltd.'s P/E ratio is -26.72. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 300676.SZ return on equity (ROE)?
BGI Genomics Co., Ltd.'s return on equity (ROE) is -6.60%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is BGI Genomics Co., Ltd.'s market cap?
BGI Genomics Co., Ltd. has a market capitalization of $15.43B.
Does 300676.SZ pay a dividend?
BGI Genomics Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 300676.SZ carry?
BGI Genomics Co., Ltd. has a debt-to-equity ratio of 0.06. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300676.SZ's profit margin?
BGI Genomics Co., Ltd. reports a net profit margin of -14.89% — the share of revenue left after every cost, including tax and interest.
What sector is 300676.SZ in?
BGI Genomics Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300676.SZ listed on?
BGI Genomics Co., Ltd. trades on SHZ under the ticker 300676.SZ.
What is 300676.SZ's 52-week range?
Over the last year BGI Genomics Co., Ltd. has traded between $32.55 and $65.00.
Related — Stocks
Popular Stocks
Screens 300676.SZ currently matches
On the figures above, BGI Genomics Co., Ltd. passes the filters for 7 of our ready-made screens, among them Low Debt Stocks, Large Cap Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.